This page lists pages that redirect to other redirect pages.
Each row contains links to the first and second redirect, as well as the target of the second redirect, which is usually the "real" target page to which the first redirect should point.
Crossed out entries have been solved.
Showing below up to 10 results in range #1 to #10.
- ARN-509 → Apalutamide (ARN-509) → Apalutamide (Erleada)
- Caplacizumab → Caplacizumab (ALX-0081) → Caplacizumab (Cablivi)
- Chronic lymphocytic leukemia (CLL) and Small lymphocytic lymphoma (SLL) → Chronic lymphocytic leukemia (CLL/SLL) → Chronic lymphocytic leukemia
- CPX-351 → Cytarabine and daunorubicin (Vyxeos) → Cytarabine and daunorubicin liposomal (Vyxeos)
- Cytomegalovirus Human Immunoglobulin (CMV Immunoglobulin-VF) → Cytomegalovirus (CMV) Human Immunoglobulin (Cytogam) → Cytomegalovirus Immune Globulin (Cytogam)
- IPI-145 → Duvelisib (IPI-145) → Duvelisib (Copiktra)
- Graft versus host → Graft versus host disease (GVHD) → Graft versus host disease
- Liver cancer → Hepatobiliary cancer → Hepatocellular carcinoma
- AG-120 → Ivosidenib (AG-120) → Ivosidenib (Tibsovo)
- Uracil-tegafur (UFT) → Tegafur-uracil (UFT) → Tegafur and uracil (UFT)